«The
integration of complex genomic data sets enabled us to discover an intricate array of genomic changes and validate one
specific change that occurs
in the vast majority of all ovarian cancers,» said lead author Paul T. Spellman, Ph.D., Lawrence Berkeley National Laboratory, Berkeley, Calif. «Significantly, we have also found new information regarding the role that the BRCA1 and BRCA2
genes play
in determining survival.»